BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33883182)

  • 1. Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.
    Hsu AJ; Tamma PD; Zhang SX
    J Clin Microbiol; 2021 Aug; 59(9):e0327620. PubMed ID: 33883182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
    Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
    J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis.
    Mercier T; Guldentops E; Lagrou K; Maertens J
    Clin Infect Dis; 2021 May; 72(9):1577-1584. PubMed ID: 32188971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
    Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
    Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
    de Heer K; Gerritsen MG; Visser CE; Leeflang MM
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012399. PubMed ID: 31107543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
    Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
    J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
    Buchheidt D; Reinwald M; Spiess B; Boch T; Hofmann WK; Groll AH; Lehrnbecher T;
    Mycoses; 2016 Feb; 59(2):67-74. PubMed ID: 26756571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.
    Badiee P; Alborzi A; Karimi M; Pourabbas B; Haddadi P; Mardaneh J; Moieni M
    J Infect Dev Ctries; 2012 Apr; 6(4):352-7. PubMed ID: 22505446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
    Horiguchi Y
    Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis.
    Hashimoto A; Yamakami Y; Kamberi P; Yamagata E; Karashima R; Nagaoka H; Nasu M
    J Clin Lab Anal; 1998; 12(5):257-62. PubMed ID: 9773954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
    Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
    J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
    Petraitiene R; Petraitis V; Bacher JD; Finkelman MA; Walsh TJ
    Med Mycol; 2015 Aug; 53(6):558-68. PubMed ID: 26129890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two non-invasive diagnostic tools for invasive aspergilosis: (1-3)-beta-D-glucan and the galactomannan assay.
    Kelaher A
    Clin Lab Sci; 2006; 19(4):222-4. PubMed ID: 17181127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Fungal Infections. A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline.
    Haydour Q; Hage CA; Carmona EM; Epelbaum O; Evans SE; Gabe LM; Knox KS; Kolls JK; Wengenack NL; Prokop LJ; Limper AH; Murad MH
    Ann Am Thorac Soc; 2019 Sep; 16(9):1179-1188. PubMed ID: 31219341
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.